|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000-14 (CONCORD-3): Analysis of individual records for 37 513 025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shaukat A, Kahi CJ, Burke CA, Rabeneck L,
Sauer BG and Rex DK: ACG Clinical guidelines: Colorectal cancer
screening 2021. Am J Gastroenterol. 116:458–479. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu X, Pan B, Sun L, Chen X, Zeng K, Hu X,
Xu T, Xu M and Wang S: Circulating exosomal miR-27a and miR-130a
Act as Novel Diagnostic And Prognostic Biomarkers Of Colorectal
Cancer. Cancer Epidemiol Biomarkers Prev. 27:746–754. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu H, Wang C, Song H, Xu Y and Ji G:
RNA-Seq profiling of circular RNAs in human colorectal cancer liver
metastasis and the potential biomarkers. Mol Cancer. 18:82019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nunoue K, Ohashi K, Okano I and Mizuno K:
LIMK-1 and LIMK-2, two members of a LIM motif-containing protein
kinase family. Oncogene. 11:701–710. 1995.PubMed/NCBI
|
|
7
|
Scott RW and Olson MF: LIM kinases:
Function, regulation and association with human disease. J Mol Med
(Berl). 85:555–568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kwon J, Seong MJ, Piao X, Jo YJ and Kim
NH: LIMK1/2 are required for actin filament and cell junction
assembly in porcine embryos developing in vitro. Asian-Australas J
Anim Sci. 33:1579–1589. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bamburg JR and Bernstein BW: Roles of
ADF/cofilin in actin polymerization and beyond. F1000 Biol Rep.
2:622010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishimura Y, Yoshioka K, Bernard O,
Bereczky B and Itoh K: A role of LIM kinase 1/cofilin pathway in
regulating endocytic trafficking of EGF receptor in human breast
cancer cells. Histochem Cell Biol. 126:627–638. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang M, Tian J, Wang R, Song M, Zhao R,
Chen H, Liu K, Shim J, Zhu F, Dong Z and Lee MH: Dasatinib inhibits
lung cancer cell growth and patient derived tumor growth in mice by
targeting LIMK1. Front Cell Dev Biol. 8:5565322020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang JB, Wu YP, Lin YZ, Cai H, Chen SH,
Sun XL, Li XD, Wei Y, Zheng QS, Xu N and Xue XY: Up-regulation of
LIMK1 expression in prostate cancer is correlated with poor
pathological features, lymph node metastases and biochemical
recurrence. J Cell Mol Med. 24:4698–4706. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao J, Li D and Fang L: MiR-128-3p
suppresses breast cancer cellular progression via targeting LIMK1.
Biomed Pharmacother. 115:1089472019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang X, Li W, Liu W, Liang H, Deng J, Wong
CC, Zhao S, Kang W, To KF, Chiu PWY, et al: LIMK1 promotes
peritoneal metastasis of gastric cancer and is a therapeutic
target. Oncogene. 40:3422–3433. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu G, Zhou Y, Zhang C and Zhang Y:
Upregulation of LIMK1 is correlated with poor prognosis and immune
infiltrates in lung adenocarcinoma. Front Genet. 12:6715852021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su J, Zhou Y, Pan Z, Shi L, Yang J, Liao
A, Liao Q and Su Q: Downregulation of LIMK1-ADF/cofilin by DADS
inhibits the migration and invasion of colon cancer. Sci Rep.
7:456242017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu YH, Lu YX, Zhang ZY, Zhang JM, Zhang
WJ, Zheng L, Lin WH, Zhang W and Li XN: SSH3 facilitates colorectal
cancer cell invasion and metastasis by affecting signaling cascades
involving LIMK1/Rac1. Am J Cancer Res. 9:1061–1073. 2019.PubMed/NCBI
|
|
18
|
Ito K and Murphy D: Application of ggplot2
to pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol.
2:e792013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q,
Li B and Liu XS: TIMER2.0 for analysis of tumor-infiltrating immune
cells. Nucleic Acids Res. 48:W509–W514. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szklarczyk D, Gable AL, Nastou KC, Lyon D,
Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al:
The STRING database in 2021: Customizable protein-protein networks,
and functional characterization of user-uploaded gene/measurement
sets. Nucleic Acids Res. 49:D605–D612. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z,
Feng T, Zhou L, Tang W, Zhan L, et al: clusterProfiler 4.0: A
universal enrichment tool for interpreting omics data. Innovation
(Camb). 2:1001412021.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robin X, Turck N, Hainard A, Tiberti N,
Lisacek F, Sanchez JC and Müller M: pROC: An open-source package
for R and S+ to analyze and compare ROC curves. BMC Bioinformatics.
12:772011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Liu Y and Zheng L: The diagnostic
and prognostic value of LIMK1/2: A pan-cancer analysis. Ann Clin
Lab Sci. 51:615–624. 2021.PubMed/NCBI
|
|
29
|
Sousa-Squiavinato ACM, Vasconcelos RI,
Gehren AS, Fernandes PV, de Oliveira IM, Boroni M and Morgado-Díaz
JA: Cofilin-1, LIMK1 and SSH1 are differentially expressed in
locally advanced colorectal cancer and according to consensus
molecular subtypes. Cancer Cell Int. 21:692021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao Q, Li R, Zhou R, Pan Z, Xu L, Ding Y
and Zhao L: LIM kinase 1 interacts with myosin-9 and
alpha-actinin-4 and promotes colorectal cancer progression. Br J
Cancer. 117:563–571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dai S, Xu S, Ye Y and Ding K:
Identification of an immune-related gene signature to improve
prognosis prediction in colorectal cancer patients. Front Genet.
11:6070092020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McConnell BV, Koto K and
Gutierrez-Hartmann A: Nuclear and cytoplasmic LIMK1 enhances human
breast cancer progression. Mol Cancer. 10:752011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Q, Jiao D, Hu H, Song J, Yan J, Wu L
and Xu LQ: Downregulation of LIMK1 level inhibits migration of lung
cancer cells and enhances sensitivity to chemotherapy drugs. Oncol
Res. 20:491–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang W, Gan N and Zhou J:
Immunohistochemical investigation of the correlation between LIM
kinase 1 expression and development and progression of human
ovarian carcinoma. J Int Med Res. 40:1067–1073. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
You T, Gao W, Wei J, Jin X, Zhao Z, Wang C
and Li Y: Overexpression of LIMK1 promotes tumor growth and
metastasis in gastric cancer. Biomed Pharmacother. 69:96–101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao CC, Zhan MN, Liu WT, Jiao Y, Zhang
YY, Lei Y, Zhang TT, Zhang CJ, Du YY, Gu KS and Wei W: Combined LIM
kinase 1 and p21-activated kinase 4 inhibitor treatment exhibits
potent preclinical antitumor efficacy in breast cancer. Cancer
Lett. 493:120–127. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang X, Fang J, Chen S, Wang W, Meng S
and Liu B: Nonconserved miR-608 suppresses prostate cancer
progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways
by targeting the 3′-UTRs of RAC2/BCL2L1 and the coding region of
PAK4. Cancer Med. 8:5716–5734. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeng Y, Ren M, Li Y, Liu Y, Chen C, Su J,
Su B, Xia H, Liu F, Jiang H, et al: Knockdown of RhoGDI2 represses
human gastric cancer cell proliferation, invasion and drug
resistance via the Rac1/Pak1/LIMK1 pathway. Cancer Lett.
492:136–146. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang S, Shi W, Hu W, Ma D, Yan D, Yu K,
Zhang G, Cao Y, Wu J, Jiang C and Wang Z: DEP domain-containing
protein 1B (DEPDC1B) promotes migration and invasion in pancreatic
cancer through the Rac1/PAK1-LIMK1-cofilin1 signaling pathway. Onco
Targets Ther. 13:1481–1496. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vainer G, Vainer-Mosse E, Pikarsky A,
Shenoy SM, Oberman F, Yeffet A, Singer RH, Pikarsky E and Yisraeli
JK: A role for VICKZ proteins in the progression of colorectal
carcinomas: Regulating lamellipodia formation. J Pathol.
215:445–456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tian T, Chen ZH, Zheng Z, Liu Y, Zhao Q,
Liu Y, Qiu H, Long Q, Chen M, Li L, et al: Investigation of the
role and mechanism of ARHGAP5-mediated colorectal cancer
metastasis. Theranostics. 10:5998–6010. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li VS, Yuen ST, Chan TL, Yan HH, Law WL,
Yeung BH, Chan AS, Tsui WY, So S, Chen X and Leung SY: Frequent
inactivation of axon guidance molecule RGMA in human colon cancer
through genetic and epigenetic mechanisms. Gastroenterology.
137:176–187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sousa-Squiavinato ACM, Rocha MR,
Barcellos-de-Souza P, de Souza WF and Morgado-Diaz JA: Cofilin-1
signaling mediates epithelial-mesenchymal transition by promoting
actin cytoskeleton reorganization and cell-cell adhesion regulation
in colorectal cancer cells. Biochim Biophys Acta Mol Cell Res.
1866:418–429. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang Y and Jobin C: Microbial imbalance
and intestinal pathologies: Connections and contributions. Dis
Model Mech. 7:1131–1142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu X, Guo J, Vorster P and Wu Y:
Involvement of LIM kinase 1 in actin polarization in human CD4 T
cells. Commun Integr Biol. 5:381–383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Duvall MG, Fuhlbrigge ME, Reilly RB,
Walker KH, Kılıç A and Levy BD: Human NK cell cytoskeletal dynamics
and cytotoxicity are regulated by LIM kinase. J Immunol.
205:801–810. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Facciabene A, Motz GT and Coukos G:
T-regulatory cells: Key players in tumor immune escape and
angiogenesis. Cancer Res. 72:2162–2171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jung KY, Cho SW, Kim YA, Kim D, Oh BC,
Park DJ and Park YJ: Cancers with higher density of
tumor-associated macrophages were associated with poor survival
rates. J Pathol Transl Med. 49:318–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang Y, Xu J, Zhang N, Chen M, Wang H and
Zhu D: Targeting the tumour immune microenvironment for cancer
therapy in human gastrointestinal malignancies. Cancer Lett.
458:123–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yin K, Xia X, Rui K, Wang T and Wang S:
Myeloid-derived suppressor cells: A new and pivotal player in
colorectal cancer progression. Front Oncol. 10:6101042020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jensen P, Carlet M, Schlenk RF, Weber A,
Kress J, Brunner I, Słabicki M, Grill G, Weisemann S, Cheng YY, et
al: Requirement for LIM kinases in acute myeloid leukemia.
Leukemia. 34:3173–3185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang Y, Li A, Shi J, Fang Y, Gu C, Cai J,
Lin C, Zhao L and Liu S: Imbalanced LIMK1 and LIMK2 expression
leads to human colorectal cancer progression and metastasis via
promoting β-catenin nuclear translocation. Cell Death Dis.
9:7492018. View Article : Google Scholar : PubMed/NCBI
|
